Flow cytometric determination of FcγRIIa (CD32) polymorphism

Journal of Immunological Methods

Volumn 294, Issue 1-2, 2004, Pages 135-144

  Van Royen Kerkhof, Annet ^a,b   Sanders, Elisabeth A M ^b   Wijngaarden, Siska ^b   Van Roon, Joel A G ^b   Voorhorst Ogink, Marleen ^a,c   Walraven, Vanessa ^b   Gerritsen, Arnout ^a,c   Van Dijk, Marc A ^a,c   Kuis, W ^b   Rijkers, Ger T ^b   Keler, Tibor ^d   Leusen, Jeanette H W ^a   Van De Winkel, Jan G J ^a,c  

^a Inst for Res in Extramural Med   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c GENMAB   (Netherlands)

^d MEDAREX INC   (United States)

Author keywords

Allotyping; Fc RIIa; Fc RIIb; Flow cytometry

Indexed keywords

CD32 ANTIGEN; FC GAMMA RECEPTOR IIA; FC RECEPTOR; FLUORESCEIN ISOTHIOCYANATE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 41H16; MONOCLONAL ANTIBODY MDE 9; UNCLASSIFIED DRUG;

ADDITION REACTION; ALLOTYPE; ANIMAL CELL; ANTIBODY LABELING; ANTIBODY SPECIFICITY; ARTICLE; BLOOD SAMPLING; CELL SURFACE; CONTROLLED STUDY; CORRELATION ANALYSIS; FLOW CYTOMETRY; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; MOLECULAR RECOGNITION; MONOCYTE; MOUSE; NONHUMAN; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ALLELES; AMINO ACID SUBSTITUTION; ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; ANTIGENS, CD; ARGININE; FLOW CYTOMETRY; GENE EXPRESSION; GENOTYPE; HISTIDINE; HOMOZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; JURKAT CELLS; MICE; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, IGG; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TRANSFECTION;

EID: 10344241983     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2004.09.010     Document Type: Article

References (35)

1. L.E. Carlsson, S. Santoso, G. Baurichter, H. Kroll, S. Papenberg, P. Eichler, N.A. Westerdaal, V. Kiefel, J.G.J. van de Winkel, and A. Greinacher Heparin-induced thrombocytopenia: new insights into the impact of the FcγRIIa-R-H131 polymorphism Blood 92 1998 1526
2. M.R. Clark, S.B. Clarkson, P.A. Ory, N. Stollman, and I.M. Goldstein Molecular basis for a polymorphism involving Fc receptor II on human monocytes J. Immunol. 143 1989 1731
3. R.A. Clynes, T.L. Towers, L.G. Presta, and J.V. Ravetch Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets Nat. Med. 6 2000 443
4. Y.M. Deo, R.F. Graziano, R. Repp, and J.G.J. van de Winkel Clinical significance of IgG Fc receptors and FcγR-directed immunotherapies Immunol. Today 18 1997 127
5. H.M. Dijstelbloem, R.H. Scheepers, W.W. Oost, C.A. Stegeman, W.L. van der Pol, W.J. Sluiter, C.G. Kallenberg, J.G.J. van de Winkel, and J.W. Tervaert Fcγ receptor polymorphisms in Wegener's granulomatosis: risk factors for disease relapse Arthritis Rheum. 42 1999 1823
6. D.M. Fishwild, S.L. O'Donnell, T. Bengoechea, D.V. Hudson, F. Harding, S.L. Bernhard, D. Jones, R.M. Kay, K.M. Higgins, S.R. Schramm, and N. Lonberg High-avidity human IgG kappa monoclonal antibodies from a novel strain of minilocus transgenic mice Nat. Biotechnol. 14 1996 845
7. E.J. Gosselin, M.F. Brown, C.L. Anderson, T.F. Zipf, and P.M. Guyre The monoclonal antibody 41H16 detects the Leu 4 responder form of human FcγRII J. Immunol. 144 1990 1817
8. L.A. Haseley, J.J. Wisnieski, M.R. Denburg, A.R. Michael-Grossman, E.M. Ginzler, M.F. Gourley, J.H. Hoffman, R.P. Kimberly, and J.E. Salmon Antibodies to C1q in systemic lupus erythematosus: characteristics and relation to FcγRIIA alleles Kidney Int. 52 1997 1375
9. F.L. Ierino, M.D. Hulett, I.F. McKenzie, and P.M. Hogarth Mapping epitopes of human FcγRII (CDw32) with monoclonal antibodies and recombinant receptors J. Immunol. 150 1993 1794
10. F.B. Karassa, T.A. Trikalinos, and J.P. Ioannidis Role of the Fcγ receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis Arthritis Rheum. 46 2002 1563
11. K.F. Maxwell, M.S. Powell, M.D. Hulett, P.A. Barton, I.F. McKenzie, T.P. Garrett, and P.M. Hogarth Crystal structure of the human leukocyte Fc receptor, FcγRIIa Nat. Struct. Biol. 6 1999 437
12. S. Miescher, M.O. Spycher, H. Amstutz, H.M. De, M. Kleijer, U.J. Kalus, H. Radtke, A. Hubsch, I. Andresen, R.M. Martin, and J. Bichler A single recombinant anti-RhD IgG prevents Rhesus D immunization: association of RhD positive red blood cell clearance rate with polymorphisms in the FcγRIIA and IIIA genes Blood 103 2004 4028
13. H.C. Morton, I.E. van den Herik-Oudijk, P. Vossebeld, A. Snijders, A.J. Verhoeven, P.J. Capel, and J.G.J. van de Winkel Functional association between the human myeloid immunoglobulin A Fc receptor (CD89) and FcR γ-chain. Molecular basis for CD89/FcR γ-chain association J. Biol. Chem. 270 1995 29781
14. J.M. Osborne, G.W. Chacko, J.T. Brandt, and C.L. Anderson Ethnic variation in frequency of an allelic polymorphism of human FcγRIIA determined with allele specific oligonucleotide probes J. Immunol. Methods 173 1994 207
15. P.W. Parren, M.E. Geerts, L.C. Boeije, and L.A. Aarden Induction of T-cell proliferation by recombinant mouse and chimeric mouse/human anti-CD3 monoclonal antibodies Res. Immunol. 142 1991 749
16. J.V. Ravetch, and S. Bolland IgG Fc receptors Annu. Rev. Immunol. 19 2001 275
17. A. Samuelsson, T.L. Towers, and J.V. Ravetch Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor Science 291 2001 484
18. L.A. Sanders, J.G.J. van de Winkel, G.T. Rijkers, M.M. Voorhorst-Ogink, M. de Haas, P.J. Capel, and B.J. Zegers Fcγ-receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections J. Infect. Dis. 170 1994 854
19. W.J. Tax, W.P. Tamboer, C.W. Jacobs, L.A. Frenken, and R.A. Koene Role of polymorphic Fc receptor Fc(RIIa in cytokine release and adverse effects of murine IgG1 anti-CD3/T cell receptor antibody (WT31) Transplantation 63 1997 106
20. T. Thepen, A.J. van Vuuren, R.C. Kiekens, C.A. Damen, W.C. Vooijs, and J.G.J. van de Winkel Resolution of cutaneous inflammation after local elimination of macrophages Nat. Biotechnol. 18 2000 48
21. S. Tridandapani, K. Siefker, J.L. Teillaud, J.E. Carter, M.D. Wewers, and C.L. Anderson Regulated expression and inhibitory function of Fc(RIIb in human monocytic cells J. Biol. Chem. 277 2002 5082
22. J.G.J. van de Winkel, and C.L. Anderson CD32 cluster workshop report Leucocyte Typing V 1995 Oxford University Press Oxford 823
23. J.G.J. van de Winkel, W.J. Tax, M.C. Van Bruggen, C.E. van Roozendaal, H.W. Willems, A. Vlug, P.J. Capel, and R.A. Koene Characterization of two Fc receptors for mouse immunoglobulins on human monocytes and cell lines Scand. J. Immunol. 26 1987 663
24. I.E. van den Herik-Oudijk Binding heterogeneity within the CD32 panel of monoclonal antibodies S. Schlossman Leucocyte Typing V 1995 Oxford University Press Oxford 832
25. I.E. van den Herik-Oudijk, N.A. Westerdaal, N.V. Henriquez, P.J. Capel, and J.G.J. van de Winkel Functional analysis of human FcγRII (CD32) isoforms expressed in B lymphocytes J. Immunol. 152 1994 574
26. W. van der Pol, and J.G.J. van de Winkel IgG receptor polymorphisms: risk factors for disease Immunogenetics 48 1998 222
27. W.L. van der Pol, M.D. Jansen, W.J. Sluiter, B. van de Sluis, F.G. Leppers-van de Straat, T. Kobayashi, R.G. Westendorp, T.W. Huizinga, and J.G.J. van de Winkel Evidence for non-random distribution of Fcγ receptor genotype combinations Immunogenetics 55 2003 240
28. N.M. van Sorge, W.L. van der Pol, and J.G.J. van de Winkel FcγR polymorphisms: implications for function, disease susceptibility and immunotherapy Tissue Antigens 61 2003 189
29. A.B. van Spriel, J.H. Leusen, H. Vile, and J.G.J. van de Winkel Mac-1 (CD11b/CD18) as accessory molecule for FcαR (CD89) binding of IgA J. Immunol. 169 2002 3831
30. B.A. Vance, K.H. Karlson, P.M. Morganelli, and P.M. Guyre Single step screening of monoclonal antibodies against interferon-induced surface molecules on human monocytes J. Immunol. Methods 118 1989 287
31. P.A. Warmerdam, J.G.J. van de Winkel, A. Vlug, N.A. Westerdaal, and P.J. Capel A single amino acid in the second Ig-like domain of the human Fcγ receptor II is critical for human IgG2 binding J. Immunol. 147 1991 1338
32. P.A. Warmerdam, N.M. Nabben, S.A. van de Graaf, J.G.J. van de Winkel, and P.J. Capel The human low affinity immunoglobulin G Fc receptor IIC gene is a result of an unequal crossover event J. Biol. Chem. 268 1993 7346
33. W.K. Weng, and R. Levy Two immunoglobulin G fragment C receptor polymorphisms independently predict response to Rituximab in patients with follicular lymphoma J. Clin. Oncol. 21 2003 3940
34. D. Wurflein, M. Dechant, B. Stockmeyer, A.L. Tutt, P. Hu, R. Repp, J.R. Kalden, J.G.J. van de Winkel, A.L. Epstein, T. Valerius, M. Glennie, and M. Gramatzki Evaluating antibodies for their capacity to induce cell-mediated lysis of malignant B cells Cancer Res. 58 1998 3051
35. A.M. Yee, H.M. Phan, R. Zuniga, J.E. Salmon, and D.M. Musher Association between FcγRIIa-R131 allotype and bacteremic pneumococcal pneumonia Clin. Infect. Dis. 30 2000 25